Melanoma immunotherapy trial shows some improvement in survival


London - Researchers in Australia reporting on an immunotherapy trial with vaccinia viral melanoma cell lysates in patients with stage IIb and III melanoma say that finding an effective adjuvant treatment for melanoma is proving to be a challenge.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.